Can teenagers use weight loss peptides safely?

Wegovy (Semaglutide) is FDA-approved for ages 12+ with obesity. Tirzepatide is being studied in adolescents. Other peptides lack safety data in teens and should be avoided. <a href='https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-weight-management-pediatric-patients-obesity' target='_blank'>FDA pediatric approval</a>